Home / Inspections / 802592

FDA Inspection 802592 — Novo Nordisk Pharmaceutical Industries LP

Novo Nordisk Pharmaceutical Industries LP — FEI 1000158576

The FDA completed an inspection of Novo Nordisk Pharmaceutical Industries LP on August 16, 2012 in Clayton, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 16, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Clayton, NC (United States)

Facility

Other inspections at this facility

  • 1269778 (NAI Fri Jun 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1041878 (NAI Fri Jan 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1035563 (NAI Thu Jan 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 892098 (NAI Thu Aug 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 734383 (NAI Fri Jul 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources